South Carolina General Assembly
123rd Session, 2019-2020

Download This Bill in Microsoft Word format

Indicates Matter Stricken
Indicates New Matter

H. 5113

STATUS INFORMATION

General Bill
Sponsors: Reps. McKnight, Alexander, Bamberg, Hart, Matthews, Brawley and Rutherford
Document Path: l:\council\bills\jn\3200ph20.docx

Introduced in the House on February 5, 2020
Currently residing in the House Committee on Labor, Commerce and Industry

Summary: Prescription insulin drug

HISTORY OF LEGISLATIVE ACTIONS

     Date      Body   Action Description with journal page number
-------------------------------------------------------------------------------
    2/5/2020  House   Introduced and read first time (House Journal-page 50)
    2/5/2020  House   Referred to Committee on Labor, Commerce and Industry 
                        (House Journal-page 50)
   3/10/2020  House   Member(s) request name added as sponsor: Rutherford

View the latest legislative information at the website

VERSIONS OF THIS BILL

2/5/2020

(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

A BILL

TO AMEND THE CODE OF LAWS OF SOUTH CAROLINA, 1976, BY ADDING SECTION 38-71-48 SO AS TO DEFINE "PRESCRIPTION INSULIN DRUG" AND REQUIRE ALL INDIVIDUAL AND GROUP HEALTH INSURANCE, HEALTH MAINTENANCE ORGANIZATIONS, AND THE STATE HEALTH PLAN TO CAP AN INSURED'S MONTHLY COST-SHARING OBLIGATION FOR COVERED PRESCRIPTION INSULIN DRUGS.

Be it enacted by the General Assembly of the State of South Carolina:

SECTION    1.    Article 1, Chapter 71, Title 38 of the 1976 Code is amended by adding:

    "Section 38-71-48.    (A)    'Prescription insulin drug' means a prescription drug that contains insulin, is used to treat diabetes, and has been prescribed as medically necessary by the treating physician.

    (B)    All health insurance plans offered by individual and group health insurers and health maintenance organizations, including the State Health Plan, providing coverage for medical treatment must cap the total amount of cost-sharing required of an insured at an amount not to exceed one hundred dollars per thirty-day supply of prescription insulin drug, regardless of the amount or type of insulin needed to fill the insured's prescription.

    (C)    This section does not prevent an insurer from reducing an insured's cost-sharing obligation by an amount greater than the amount specified in subsection (B).

    (D)    The Department of Insurance may adopt rules and regulations to administer this section."

SECTION    2.    This act takes effect upon approval by the Governor and applies to health insurance plans issued, renewed, delivered, or entered into after June 30, 2020.

----XX----


This web page was last updated on March 10, 2020 at 3:07 PM